Preemptive renal replacement therapy in post-cardiotomy cardiogenic shock patients: a new concept? | Zendy

JeanPierre Quenot | Zendy; Marine Jacquier | Zendy; Auguste Dargent | Zendy; Jean-Baptiste Roudaut | Zendy; Pascal Andreu | Zendy; François Aptel | Zendy; Marie Labruyère | Zendy; Saber Davide Barbar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Preemptive renal replacement therapy in post-cardiotomy cardiogenic shock patients: a new concept?

Author(s) -

JeanPierre Quenot,

Marine Jacquier,

Auguste Dargent,

Jean-Baptiste Roudaut,

Pascal Andreu,

François Aptel,

Marie Labruyère,

Saber Davide Barbar

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - French

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.03.100

Subject(s) - cardiogenic shock , cardiotomy , medicine , renal replacement therapy , intensive care medicine , cardiology , myocardial infarction , cardiopulmonary bypass

Service de Médecine Intensive-Réanimation, CHU Dijon Bourgogne, France; INSERM, U1231, Equipe Lipness, Dijon, France; INSERM, CIC 1432, Faculté des sciences de la santé, Dijon, France; Médecine Intensive Réanimation, Hôpital Edouard Herriot, Lyon, France; Service de Réanimation, CHU de Nîmes, France; Université de Montpellier, Faculté de Médecine de Montpellier-Nîmes, EA 2992, Nîmes, France Correspondence to: Jean-Pierre Quenot. Service de Médecine Intensive-Réanimation, CHU Dijon Bourgogne, 14 rue Paul Gaffarel, 21079 Dijon, France. Email: jean-pierre.quenot@chu-dijon.fr. Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Tu GW, Xu JR, Liu L, et al. Preemptive renal replacement therapy in post-cardiotomy cardiogenic shock patients: a historically controlled cohort study. Ann Transl Med 2019;7:534.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research